KR840007882A - 디히드로피리딘 유도체 및 그 제법 - Google Patents
디히드로피리딘 유도체 및 그 제법 Download PDFInfo
- Publication number
- KR840007882A KR840007882A KR1019840001072A KR840001072A KR840007882A KR 840007882 A KR840007882 A KR 840007882A KR 1019840001072 A KR1019840001072 A KR 1019840001072A KR 840001072 A KR840001072 A KR 840001072A KR 840007882 A KR840007882 A KR 840007882A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- general formula
- hydrogen
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58036211A JPS59161392A (ja) | 1983-03-04 | 1983-03-04 | ジヒドロピリジン誘導体及びその製法 |
| JP36211 | 1983-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR840007882A true KR840007882A (ko) | 1984-12-11 |
Family
ID=12463415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019840001072A Ceased KR840007882A (ko) | 1983-03-04 | 1984-03-03 | 디히드로피리딘 유도체 및 그 제법 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4535073A (enExample) |
| EP (1) | EP0121117B1 (enExample) |
| JP (1) | JPS59161392A (enExample) |
| KR (1) | KR840007882A (enExample) |
| CA (1) | CA1254206A (enExample) |
| DE (1) | DE3479582D1 (enExample) |
| ES (2) | ES8505379A1 (enExample) |
| GB (1) | GB2140015B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6069089A (ja) * | 1983-09-26 | 1985-04-19 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホネ−ト誘導体およびその製造法 |
| EP0141222B1 (en) * | 1983-09-26 | 1989-04-12 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic ester |
| EP0141221A1 (en) * | 1983-09-26 | 1985-05-15 | Nissan Chemical Industries Ltd. | 1,4-Dihydropyridine-5-phosphonic acid ester |
| JPS6130591A (ja) * | 1984-07-20 | 1986-02-12 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホネ−ト誘導体 |
| JPS60248693A (ja) * | 1984-04-19 | 1985-12-09 | Nippon Shinyaku Co Ltd | ピリジン誘導体及び製法 |
| JPS6127995A (ja) * | 1984-07-18 | 1986-02-07 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホン酸モノエステル誘導体およびその製造法 |
| IT1201444B (it) * | 1985-08-01 | 1989-02-02 | Boehringer Biochemia Srl | Fosfonopiridine a loro 1,4-diidroderivati |
| IT1215298B (it) * | 1985-08-06 | 1990-01-31 | Boehringer Biochemia Srl | 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione. |
| US4885284A (en) * | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
| CN1016063B (zh) | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
| JPH0699458B2 (ja) * | 1986-01-23 | 1994-12-07 | 日産化学工業株式会社 | ジヒドロピリジン−5−ホスホン酸環状エステル類 |
| JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2位置換1,4−ジヒドロピリジン誘導体 |
| US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
| JP2850376B2 (ja) * | 1988-08-02 | 1999-01-27 | 日産化学工業株式会社 | 抗癌剤薬効増強剤 |
| ATE128623T1 (de) * | 1988-08-02 | 1995-10-15 | Nissan Chemical Ind Ltd | Mittel zur verbesserung von arzneimitteleffekten für antitumormittel. |
| NZ542681A (en) | 2003-03-28 | 2009-01-31 | Nissan Chemical Ind Ltd | T-type calcium channel blockers comprising optically active 1,4-dihydropyridines |
| ES2557407T3 (es) | 2010-03-01 | 2016-01-25 | Tau Therapeutics Llc | Procedimiento de imaginología de una enfermedad |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
-
1983
- 1983-03-04 JP JP58036211A patent/JPS59161392A/ja active Granted
-
1984
- 1984-02-20 GB GB08404386A patent/GB2140015B/en not_active Expired
- 1984-03-02 EP EP84102249A patent/EP0121117B1/en not_active Expired
- 1984-03-02 DE DE8484102249T patent/DE3479582D1/de not_active Expired
- 1984-03-02 ES ES530248A patent/ES8505379A1/es not_active Expired
- 1984-03-02 US US06/585,574 patent/US4535073A/en not_active Expired - Fee Related
- 1984-03-02 CA CA000448718A patent/CA1254206A/en not_active Expired
- 1984-03-03 KR KR1019840001072A patent/KR840007882A/ko not_active Ceased
- 1984-11-16 ES ES537717A patent/ES537717A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB8404386D0 (en) | 1984-03-28 |
| JPH0365351B2 (enExample) | 1991-10-11 |
| ES530248A0 (es) | 1985-05-16 |
| ES8603902A1 (es) | 1986-01-01 |
| CA1254206A (en) | 1989-05-16 |
| EP0121117A1 (en) | 1984-10-10 |
| ES8505379A1 (es) | 1985-05-16 |
| GB2140015A (en) | 1984-11-21 |
| ES537717A0 (es) | 1986-01-01 |
| JPS59161392A (ja) | 1984-09-12 |
| EP0121117B1 (en) | 1989-08-30 |
| DE3479582D1 (en) | 1989-10-05 |
| US4535073A (en) | 1985-08-13 |
| GB2140015B (en) | 1987-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840007882A (ko) | 디히드로피리딘 유도체 및 그 제법 | |
| KR860003243A (ko) | 타아졸리딘디온 유도체의 제조방법 | |
| KR860001104A (ko) | 테트라히드로프탈이미드의 제조방법 | |
| KR840004406A (ko) | 히단토인의 제조방법 | |
| KR870008889A (ko) | 베타-락탐화합물, 및 그의 제조 방법 | |
| KR870010005A (ko) | 퀴놀린 유도체 및 그의 에스테르 또는 염의 제조법 | |
| KR850005829A (ko) | 2-시아노벤즈이미다졸 유도체의 제조방법 | |
| KR850001184A (ko) | 1,5-벤조티아제핀 유도체의 제조방법 | |
| KR840006324A (ko) | 2-니트로-1,1-에렌디아민의 제조방법 | |
| KR860001065A (ko) | 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법 | |
| KR850007603A (ko) | 피리딘 유도체 및 그 제조방법 | |
| KR840005723A (ko) | 티아졸유도체의 제조방법 | |
| KR870004025A (ko) | 헤테로시클로카보닐-및 아세틸-티아졸론의 제조방법 | |
| KR830008489A (ko) | N-아실 아미노산 유도체의 제조방법 | |
| KR840008647A (ko) | 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법 | |
| KR860003204A (ko) | 디페닐메틸이민 유도체의 제조방법 | |
| KR830005122A (ko) | 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법 | |
| KR860000295A (ko) | 옥시캄 유도체의 제조방법 | |
| KR880000429A (ko) | T-부틸 에르골린 유도체 | |
| KR900003178A (ko) | 세펨 화합물의 제조방법 | |
| KR860009006A (ko) | 2-티오크로메닐리덴아세토아세트산 에스테르의 제조방법 | |
| KR870007898A (ko) | 벤조[h]신놀린 화합물의 제조방법 | |
| KR890014490A (ko) | 구아니딘 유도체의 제조방법 | |
| KR870001221A (ko) | 피리미도-[2,1-b]벤조티아졸 및 그의 염 제조방법 | |
| KR850005413A (ko) | 아미노니트로피리딘의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19840303 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19890306 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19840303 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19910905 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19911126 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19910905 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |